These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8275460)
1. Concordance between karyotyping and in situ hybridization procedures in the detection of monosomy 9 in bladder cancer. Smeets W; Schapers R; Hopman A; Pauwels R; Ramaekers F Cancer Genet Cytogenet; 1993 Nov; 71(1):97-9. PubMed ID: 8275460 [TBL] [Abstract][Full Text] [Related]
2. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma. Eleuteri P; Grollino MG; Pomponi D; De Vita R Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956 [TBL] [Abstract][Full Text] [Related]
3. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781 [TBL] [Abstract][Full Text] [Related]
4. A case of transitional cell carcinoma of the bladder with a del(9)(q11q21.2). Bernués M; Casadevall C; Miró R; Caballín MR; Gelabert A; Egozcue J Cancer Genet Cytogenet; 1993 Aug; 69(1):76-7. PubMed ID: 8374907 [TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC. Eleuteri P; Grollino MG; Pomponi D; Calugi G; Rocchi M; De Vita R Eur J Histochem; 1997; 41 Suppl 2():161-2. PubMed ID: 9859830 [No Abstract] [Full Text] [Related]
6. Nonrandom changes of chromosome 10 in bladder cancer. Detection by FISH to interphase nuclei. Wang MR; Perissel B; Taillandier J; Kémény JL; Fonck Y; Lautier A; Benkhalifa M; Malet P Cancer Genet Cytogenet; 1994 Mar; 73(1):8-10. PubMed ID: 8174080 [TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior. Yu DS; Chen HI; Chang SY Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044 [TBL] [Abstract][Full Text] [Related]
8. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization]. Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751 [TBL] [Abstract][Full Text] [Related]
9. Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe. Poddighe PJ; Ramaekers FC; Smeets AW; Vooijs GP; Hopman AH Cancer Res; 1992 Sep; 52(18):4929-34. PubMed ID: 1516049 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of numerical chromosomal aberrations in bladder cancer detected by fluorescence in situ hybridization]. Oka F Nihon Ika Daigaku Zasshi; 1995 Oct; 62(5):501-10. PubMed ID: 7499466 [TBL] [Abstract][Full Text] [Related]
11. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis. Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302 [TBL] [Abstract][Full Text] [Related]
12. Interphase cytogenetic studies of bladder cancer. Wang MR; Perissel B; Taillandier J; Malet P Bull Cancer; 1994 Dec; 81(12):1060-6. PubMed ID: 7742594 [TBL] [Abstract][Full Text] [Related]
13. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer. Matsuyama H; Bergerheim US; Nilsson I; Pan Y; Skoog L; Tribukait B; Ekman P Cancer Genet Cytogenet; 1994 Oct; 77(2):118-24. PubMed ID: 7954321 [TBL] [Abstract][Full Text] [Related]
14. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization. Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535 [TBL] [Abstract][Full Text] [Related]
15. Detection of genetic aberrations in bladder cancer using in situ hybridization. Ramaekers FC; Hopman AH Ann N Y Acad Sci; 1993 Mar; 677():199-213. PubMed ID: 8098592 [No Abstract] [Full Text] [Related]
16. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH]. Shou J; Wang M; Ma J Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593 [TBL] [Abstract][Full Text] [Related]
17. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281 [TBL] [Abstract][Full Text] [Related]
18. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder? Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132 [TBL] [Abstract][Full Text] [Related]
19. Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization. Yokogi H; Wada Y; Moriyama-Gonda N; Igawa M; Ishibe T Br J Urol; 1996 Nov; 78(5):699-703. PubMed ID: 8976763 [TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]